OCA
JNCE

Octagon Capital Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Octagon Capital Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,400,000
Closed -$1.55M – 45
2022
Q4 		$1.55M Hold
1,400,000
– – 0.24% 29
2022
Q3 		$3.28M Buy
+1,400,000
New +$3.28M 0.57% 25